Anti-tumoral effects of novel lymphatic delivery of anti-CTLA-4 in a metastatic murine breast cancer model

被引：0
|
作者：
Kwon, Sunkuk [1 ]
Velasquez, Fred Christian [1 ]
Ross, Russel F. [2 ]
Hwu, Wen-Jen [3 ]
Sevick-Muraca, Eva M. [1 ]
机构：
[1] Univ Texas Hlth Sci Ctr Houston, Houston, TX 77030 USA
[2] Kimberly Clark Inc, Roswell, GA USA
[3] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
CANCER RESEARCH | 2018年 / 78卷 / 13期
关键词：
D O I：
10.1158/1538-7445.AM2018-LB-005
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
LB-005
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Anti-tumor immunological response induced by cryoablation and anti-CTLA-4 antibody in an in vivo RM-1 cell prostate cancer murine model
    Li, F.
    Guo, Z.
    Yu, H.
    Zhang, X.
    Si, T.
    Liu, C.
    Yang, X.
    Qi, L.
    NEOPLASMA, 2014, 61 (06) : 659 - 671
  • [42] An In Vitro Model of Mast Cell Recruitment and Activation by Breast Cancer Cells Supports Anti-Tumoral Responses
    Aponte-Lopez, Angelica
    Enciso, Jennifer
    Munoz-Cruz, Samira
    Fuentes-Panana, Ezequiel M.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (15) : 1 - 19
  • [43] Systemic Delivery of the Cancer Gene Therapy Biologic, SNS01, Has Significant Anti-Tumoral Activity in a Murine Model of Multiple Myeloma
    Taylor, Catherine A.
    Lust, John A.
    Ye, Bin
    Liu, Zhongda
    Sun, Zhong
    Dondero, Richard S.
    Galton, Bruce
    Donovan, Kathleen A.
    Thompson, John E.
    BLOOD, 2009, 114 (22) : 971 - 971
  • [44] Effects of corticosteroids on tumor immunity induced by anti-CTLA-4 mAb therapy in a mouse model
    Maeda, Yuka
    Kato, Takuma
    Wang, Linan
    Muraoka, Daisuke
    Sato, Eiichi
    Wolchok, Jedd D.
    Old, Lloyd J.
    Shiku, Hiroshi
    Nishikawa, Hiroyoshi
    CANCER RESEARCH, 2010, 70
  • [45] Ipilimumab (Anti-Ctla-4 Mab) in the treatment of metastatic melanoma: Effectiveness and toxicity management
    Savoia, Paola
    Astrua, Chiara
    Fava, Paolo
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2016, 12 (05) : 1092 - 1101
  • [46] Antitumor Immunity Augmented by Combining Radiofrequency Ablation with Anti-CTLA-4 Therapy in a Subcutaneous Murine Hepatoma Model
    Zhang, Liang
    Xu, Lichao
    Wang, Ying
    Liu, Xiaofei
    Zhang, Mingming
    Li, Wentao
    JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 2020, 31 (07) : 1178 - 1186
  • [47] Anti-PD-1 and Anti-CTLA-4 Therapies in Cancer: Mechanisms of Action, efficacy, and Limitations
    Seidel, Judith A.
    Otsuka, Atsushi
    Kabashima, Kenji
    FRONTIERS IN ONCOLOGY, 2018, 8
  • [48] Inflammatory bowel disease and cancer response due to anti-CTLA-4: is it in the flora?
    Carbonnel, Franck
    Soularue, Emilie
    Coutzac, Clelia
    Chaput, Nathalie
    Mateus, Christine
    Lepage, Patricia
    Robert, Caroline
    SEMINARS IN IMMUNOPATHOLOGY, 2017, 39 (03) : 327 - 331
  • [49] Novel bio-inspired lipid nanoparticles for improving the anti-tumoral efficacy of fisetin against breast cancer
    Talaat, Sara M.
    Elnaggar, Yosra S. R.
    El-Ganainy, Samar O.
    Gowayed, Mennatallah A.
    Abdel-Bary, Amany
    Abdallah, Ossama Y.
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2022, 628
  • [50] Inflammatory bowel disease and cancer response due to anti-CTLA-4: is it in the flora?
    Franck Carbonnel
    Emilie Soularue
    Clélia Coutzac
    Nathalie Chaput
    Christine Mateus
    Patricia Lepage
    Caroline Robert
    Seminars in Immunopathology, 2017, 39 : 327 - 331
12345